Item Type | Name |
Concept
|
Melanoma
|
Concept
|
Melanoma, Experimental
|
Academic Article
|
Patterns of failure in anorectal melanoma. A guide to surgical therapy.
|
Academic Article
|
Surgical management and prognostic factors in patients with subungual melanoma.
|
Academic Article
|
Prevention and early detection of melanoma: a surgeon's perspective.
|
Academic Article
|
Cranial irradiation after surgical excision of brain metastases in melanoma patients.
|
Academic Article
|
Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.
|
Academic Article
|
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
|
Academic Article
|
A new American Joint Committee on Cancer staging system for cutaneous melanoma.
|
Academic Article
|
New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
|
Academic Article
|
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.
|
Academic Article
|
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
|
Academic Article
|
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies.
|
Academic Article
|
The current management of cutaneous melanoma.
|
Academic Article
|
Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid).
|
Academic Article
|
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.
|
Academic Article
|
Cutaneous melanoma: current practice and surgical controversies.
|
Academic Article
|
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
|
Academic Article
|
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
|
Academic Article
|
Melanoma patients with iliac nodal metastases can be cured.
|
Academic Article
|
Surgery for abdominal metastases of cutaneous melanoma.
|
Academic Article
|
The new melanoma staging system.
|
Academic Article
|
Sentinel node biopsy and standard of care for melanoma.
|
Academic Article
|
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
|
Academic Article
|
Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer Center.
|
Academic Article
|
Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo.
|
Academic Article
|
Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.
|
Academic Article
|
Prognostic implications of DNA index in patients with stage III cutaneous melanoma.
|
Academic Article
|
Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.
|
Academic Article
|
Recent advances in the care of the patient with malignant melanoma.
|
Academic Article
|
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
|
Academic Article
|
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
|
Academic Article
|
The importance of lymphatic anatomy in melanoma--a resurgence of clinical significance in an era of sentinel lymph node technology.
|
Academic Article
|
Sentinel lymphadenectomy for melanoma--is it a substitute for elective lymphadenectomy?
|
Academic Article
|
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
|
Academic Article
|
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
|
Academic Article
|
An evidence-based staging system for cutaneous melanoma.
|
Academic Article
|
Protocol for the examination of specimens from patients with melanoma of the skin.
|
Academic Article
|
2010 TNM staging system for cutaneous melanoma...and beyond.
|
Academic Article
|
Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.
|
Academic Article
|
Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.
|
Academic Article
|
Age as a prognostic factor in patients with localized melanoma and regional metastases.
|
Academic Article
|
Role of uncultured human melanoma cells in the proliferation of autologous tumor-specific cytotoxic T lymphocytes.
|
Academic Article
|
Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.
|
Academic Article
|
Final version of 2009 AJCC melanoma staging and classification.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.
|
Academic Article
|
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma.
|
Academic Article
|
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
|
Academic Article
|
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.
|
Academic Article
|
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
|
Academic Article
|
Clinical value of the sentinel-node biopsy in primary cutaneous melanoma.
|
Academic Article
|
Lymphatic Mapping and Sentinel Node Biopsy in Melanoma.
|
Academic Article
|
Clinical value of the sentinel-node biopsy in primary cutaneous melanoma
|
Academic Article
|
Excision Margins of Melanoma Make a Difference
|
Academic Article
|
Prostaglandin-mediated suppression of immunocompetence in patients with melanoma
|
Academic Article
|
Excision margins for primary cutaneous melanoma - Invited critique
|
Academic Article
|
Balancing benefits and risks of melanoma treatment
|
Academic Article
|
A randomized evaluation of adjunctive chemoimmunotherapy versus immunotherapy in patients with resected metastatic melanoma
|
Academic Article
|
Modulation of mitogen response by indomethacin in melanoma patients is not related to prostaglandin E2
|
Academic Article
|
Cyclophosphamide (C) plus DTIC (D) alone or with piperazinedione (P) in melanoma
|
Academic Article
|
Site of metastasis influences monoclonal antibody uptake by human melanoma xenografts in nude mice
|
Academic Article
|
Surgical excision margins for primary cutaneous melanoma
|
Academic Article
|
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
|
Academic Article
|
Cutaneous melanoma: prognosis and treatment results worldwide.
|
Academic Article
|
Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection.
|
Academic Article
|
Predicting survival and recurrence in localized melanoma: a multivariate approach.
|
Academic Article
|
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
|
Academic Article
|
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
|
Academic Article
|
Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone.
|
Academic Article
|
Surgery as palliative treatment for distant metastases of melanoma.
|
Academic Article
|
Corynebacterium parvum versus bacille Calmette-Gu?rin adjuvant immunotherapy of stage II malignant melanoma.
|
Academic Article
|
Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.
|
Academic Article
|
[Diagnosis and prognosis of malignant melanoma].
|
Academic Article
|
Excising melanomas: how wide is enough? And how to reconstruct?
|
Academic Article
|
Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.
|
Academic Article
|
The surgeon's expanded role in cancer care.
|
Academic Article
|
In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.
|
Academic Article
|
Humoral modulation of lymphokine-activated killer (LAK)-cell induction in humans: IgG-related and non-IgG inhibitors in sera from cancer patients.
|
Academic Article
|
Axillary lymph node dissection: differences in goals and techniques when treating melanoma and breast cancer.
|
Academic Article
|
Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.
|
Academic Article
|
Altered biodistribution of indium-111-labeled monoclonal antibody 96.5 to tumors and normal tissues of nude mice bearing human melanoma xenografts in visceral organs.
|
Academic Article
|
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases.
|
Academic Article
|
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
|
Academic Article
|
Three unresolved issues in the surgical treatment of melanoma.
|
Academic Article
|
The role of elective lymph node dissection in melanoma: rationale, results, and controversies.
|
Academic Article
|
Cutaneous melanoma: a review of clinical management.
|
Academic Article
|
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
|
Academic Article
|
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO).
|
Academic Article
|
Surgical controversies in melanoma.
|
Academic Article
|
[Malignant melanoma--compared worldwide].
|
Academic Article
|
Prognostic histopathological factors in malignant melanoma.
|
Academic Article
|
[Therapy of malignant melanoma].
|
Academic Article
|
Current status and future prospects for adjuvant therapy of melanoma.
|
Academic Article
|
The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments.
|
Academic Article
|
Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
|
Academic Article
|
The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
|
Academic Article
|
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
|
Academic Article
|
Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients.
|
Academic Article
|
How patient referral bias can confuse interpretation of clinical results: elective lymph node dissections at the Sydney Melanoma Unit.
|
Academic Article
|
Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia.
|
Academic Article
|
Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients.
|
Academic Article
|
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy.
|
Academic Article
|
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.
|
Academic Article
|
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
|
Academic Article
|
Surgical management of regional lymph nodes in cutaneous melanoma.
|
Academic Article
|
Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
|
Academic Article
|
Management of cutaneous melanoma in the United States.
|
Academic Article
|
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
|
Academic Article
|
Oral and cutaneous melanoma: clinical recognition, pathological features, and prognostic factors.
|
Academic Article
|
The prognostic significance of ulceration of cutaneous melanoma.
|
Academic Article
|
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.
|
Academic Article
|
Think melanoma.
|
Academic Article
|
"Iris" technique for immediate umbilical reconstruction.
|
Academic Article
|
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.
|
Academic Article
|
Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
|
Academic Article
|
Finally, a successful adjuvant therapy for high-risk melanoma.
|
Academic Article
|
Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value.
|
Academic Article
|
Factors affecting survival following local, regional, or distant recurrence from localized melanoma.
|
Academic Article
|
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial.
|
Academic Article
|
The John Wayne Clinical Research Lecture. Surgical management of melanoma: results of prospective randomized trials.
|
Academic Article
|
Classification of localized melanoma by the exponential survival trees method.
|
Academic Article
|
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.
|
Academic Article
|
Society of Surgical Oncology practice guidelines. Melanoma surgical practice guidelines.
|
Academic Article
|
Randomized surgical trials involving elective node dissection for melanoma.
|
Academic Article
|
Soft tissue masses of the chest wall and axilla: has metastatic melanoma been considered?
|
Academic Article
|
Is the capacity for lymph node-mediated distant dissemination the same for all nodal groups in malignant melanoma?
|
Academic Article
|
Clinical outcomes of localized melanoma of the foot: a case-control study.
|
Academic Article
|
Palliative surgery for stage IV melanoma: is it a primary treatment?
|
Academic Article
|
Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11). American Joint Committee on Cancer.
|
Academic Article
|
The new melanoma staging system.
|
Academic Article
|
Protocol for the examination of specimens from patients with melanoma of the skin.
|
Academic Article
|
Nomograms and staging in melanoma: new tools for better predicting outcomes.
|
Academic Article
|
Melanoma in children: heightened awareness of an uncommon but often curable malignancy.
|
Academic Article
|
Screening for cutaneous melanoma.
|
Academic Article
|
Sentinel-node biopsy in melanoma.
|
Academic Article
|
An integrated tree-based classification approach to prognostic grouping with application to localized melanoma patients.
|
Academic Article
|
Method of biopsy and incidence of positive margins in primary melanoma.
|
Academic Article
|
Lymph node biopsy results for desmoplastic malignant melanoma.
|
Academic Article
|
Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
|
Academic Article
|
Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.
|
Academic Article
|
Predicting outcomes in metastatic melanoma.
|
Academic Article
|
Sorting through the heterogeneity of recurrent melanoma.
|
Academic Article
|
Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
|
Academic Article
|
Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
|
Academic Article
|
Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging.
|
Academic Article
|
Surgical excision margins for primary cutaneous melanoma.
|
Academic Article
|
National assessment of melanoma care using formally developed quality indicators.
|
Academic Article
|
Parametric modeling of localized melanoma prognosis and outcome.
|
Academic Article
|
How pathologic staging informs the surgical management of primary cutaneous melanoma.
|
Academic Article
|
Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
|
Academic Article
|
Melanoma in the older patient: measuring frailty as an index of survival.
|
Academic Article
|
Comanaging an organ transplantation and melanoma.
|
Academic Article
|
Identifying early melanomas at higher risk for metastases.
|
Academic Article
|
Balancing benefits and risks of melanoma treatment: what do we tell our patients?
|
Academic Article
|
Decreased Survival Rates of Older-Aged Patients with Melanoma: Biological Differences or Undertreatment?
|
Academic Article
|
Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).
|
Academic Article
|
Uncertainties in the management of melanoma nodal metastasis.
|
Academic Article
|
Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm.
|
Academic Article
|
Donald L. Morton, MD.... A Legendary Surgical Oncologist and Consummate Investigator.
|
Academic Article
|
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
|
Academic Article
|
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
|
Academic Article
|
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
|
Academic Article
|
Management of Sentinel-Node Metastasis in Melanoma.
|
Academic Article
|
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
|
Academic Article
|
Detection of melanoma metastases with the sentinel node biopsy: the legacy of Donald L. Morton, MD (1934-2014).
|
Academic Article
|
National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
|
Academic Article
|
Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?
|
Concept
|
Melanoma-Specific Antigens
|
Academic Article
|
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma.
|
Academic Article
|
Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.
|
Academic Article
|
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
|
Academic Article
|
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
|
Academic Article
|
Letter to the Editor Concerning "An Evidence-Based Staging System for Mucosal Melanoma: A Proposal," by Smith, Henry et al.
|
Academic Article
|
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
|
Academic Article
|
Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
|